Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing

Resectable gastric or gastroesophageal (G/GEJ) cancer is a heterogeneous disease with no defined molecularly based treatment strategy. Unfortunately, nearly half of patients experience disease recurrence despite standard treatments (neoadjuvant and/or adjuvant chemotherapy/chemoradiotherapy and surg...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavacchi, Daniele, Fancelli, Sara, Buttitta, Eleonora, Vannini, Gianmarco, Guidolin, Alessia, Winchler, Costanza, Caliman, Enrico, Vannini, Agnese, Giommoni, Elisa, Brugia, Marco, Cianchi, Fabio, Pillozzi, Serena, Roviello, Giandomenico, Antonuzzo, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003389/
https://www.ncbi.nlm.nih.gov/pubmed/36902306
http://dx.doi.org/10.3390/ijms24054877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003389/
https://www.ncbi.nlm.nih.gov/pubmed/36902306
http://dx.doi.org/10.3390/ijms24054877

Ejemplares similares